Immune-based Cancer Treatment: The T Iymphocyte Response, 1st Edition (Hardback) book cover

Immune-based Cancer Treatment

The T Iymphocyte Response, 1st Edition

Edited by Michael A. Alexander

CRC Press

250 pages

Purchasing Options:$ = USD
Hardback: 9781578087037
pub: 2011-01-21
$165.00
x
eBook (VitalSource) : 9780429063220
pub: 2011-01-21
from $28.98


FREE Standard Shipping!

Description

The culmination of 30 years of research and experience in T-cell-based cancer, this book highlights and evaluates new treatments that harness the power of the T cell to attack and kill all cancer cells in our bodies. It describes how the T cell immune system can be manipulated and redirected to kill resistant cancer cells by understanding and influencing the interaction of many different immune cells in the body. Citing current experimental trials, it examines the role and pathology of T-cells and suggests additional experimental approaches to the problem.

Table of Contents

Introduction

Which cells control the anti-cancer T cell immune response?

Antigen presentation

T cells and cancer cells: Components of immune-based anti-cancer therapy

Anti-cancer vaccines: New approaches

How and why do we get cancer and can immune-based anti-cancer therapy save us?

Immunotherapeutic approaches to the treatment of leukemia

Cancer-induced autoimmunity

Cancer stem cell: Can we solve the cancer stem cell program and cure cancer using T cell-based immunotherapy?

Translational immunology and its impact on anti-cancer T cell immunity and the development of immuno-therapeutic treatments for cancer

Dendritic cells, immunotherapy and the anti-cancer T cell response

Regulatory T cells and dendritic cells and the success of immunotherapeutic treatments for cancer

NK cells and their role in the development of immune-based anti-cancer therapy

How cancer cells influence the anti-cancer T cell response and why this is a problem during the immunotherapeutic treatment of cancer

The T cell anti-cancer response, T cell regulation and immunotherapy of neural crest cancers

The immunological hole: Will we fall in?

Summary and concluding remarks

References

Subject Categories

BISAC Subject Codes/Headings:
MED044000
MEDICAL / Immunology
MED062000
MEDICAL / Oncology